Objectives: Reducing the incidence of phlebitis and its complications
Design: The study population will consist of 60 patients admitted to the CCU of Tehran Heart Center Hospital due to atrial fibrillation or ventricular tachycardia, for which Amiodarone is administered. The patients, who are not blinded and provide informed consent, will be randomly divided into 2 groups (with and without splints) (clinical trial, phase I).
Method: After the administration of Amiodarone due to atrial fibrillation or ventricular tachycardia, the patients will be randomly allocated to one of the 2 groups. Hand splinting was performed for case group by a trained nurse.
Inclusion criteria: Age between 18 and 65 years, Amiodarone administration for atrial fibrillation or ventricular tachycardia, Starting dose of Amiodarone administration at CCU, Informed consent of the patient regarding the use of the splint, no history of cancer and chemotherapy, absence of deep vein thrombosis, no history of renal failure and dialysis, and non-consumption of broad-spectrum antibiotics and steroids
Interventions: Hand splinting in case group by a trained nurse who has been well-trained in the field of splinting in orthopedic emergencies through the academic training courses
Main outcome: Phlebitis and infection at the site of phlebitis